SC
PODD icon

Scholtz & Company’s Insulet PODD Stock Holding History

Scholtz & Company’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.18M Buy
15,164
+2,188
+17% +$550K 1.63% 28
2025
Q4 		$3.69M Buy
12,976
+1,718
+15% +$537K 1.6% 26
2025
Q3 		$3.48M Buy
11,258
+1,912
+20% +$599K 1.53% 25
2025
Q2 		$2.94M Sell
9,346
-6
-0.1% -$1.73K 1.29% 30
2025
Q1 		$2.46M Buy
9,352
+272
+3% +$73.6K 1.22% 27
2024
Q4 		$2.37M Buy
9,080
+669
+8% +$168K 1.13% 28
2024
Q3 		$1.96M Sell
8,411
-740
-8% -$152K 0.92% 30
2024
Q2 		$1.85M Buy
+9,151
New +$1.65M 0.79% 30

Other funds holding PODD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Scholtz & Company's PODD Position: Q1 2026 in Review

Scholtz & Company increased its Insulet (PODD) stake by 17% in Q1 2026, buying an estimated $550K and bringing the position to 15,164 shares worth $3.18M. The position accounts for 1.63% of the portfolio, ranked #28.

Scholtz & Company first reported a position in PODD in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.69M in Q4 2025. 784 funds tracked by Wall St. Rank hold PODD as of Q1 2026.

  • Scholtz & Company held 15,164 shares of Insulet worth $3.18M as of Q1 2026.
  • Scholtz & Company bought 2,188 Insulet shares in Q1 2026, an estimated $550K.
  • Insulet made up 1.63% of Scholtz & Company's portfolio in Q1 2026, its #28 holding.
  • Scholtz & Company first reported a position in Insulet in Q2 2024 and has held it in 8 quarters since.
  • Scholtz & Company's Insulet position peaked at $3.69M in Q4 2025.
  • 784 funds tracked by Wall St. Rank held Insulet as of Q1 2026.

Based on Scholtz & Company's 13F filing for Q1 2026, filed 15 May 2026.